Canadian scientists say they've determined stem cells from adult skin can be transplanted and remain functional.
The researchers say such stem cells create neural cell types that function in mouse models of disease.
Scientists at Toronto's Hospital for Sick Children, the University of Calgary, and the University of Toronto previously discovered what type of cells can be made from skin-derived precursors, or SKPs. In addition to generating the peripheral nervous system, neural crest stem cells generate other tissues, such as bone, cartilage, and even part of the heart.
The research team found SKPs can efficiently generate a type of glial cell -- called Schwann cells -- that can myelinate demyelinated axons and have been shown to provide a good growth environment for injured central nervous system axons that do not regenerate.
"Our finding ... raises the possibility that we could treat humans with Schwann cells derived from human skin stem cells, and perhaps even use the patient's own skin to generate Schwann cells for treatment," said Dr. Freda Miller, the study's principal investigator.
The research is reported in The Journal of Neuroscience.
Copyright 2006 by United Press International
Related stories:
Molecular switch found in mice could lead to future obesity treatments
A surprise discovery -- that calorie-burning brown fat can be produced experimentally from muscle precursor cells in mice -- raises the prospect of new ways to fight obesity and overweight, say scientists from Dana-Farber Cancer Institute.
Researcher develops novel method to grow human embryonic stem cells
(PhysOrg.com) -- The majority of researchers working with human embryonic stem cells (hESCs) – cells which produce any type of specialized adult cells in the human body – use animal-based materials for culturing the cells. But because these materials are animal-based, they could transmit viruses and other pathogens to the hESCs, making the cells unsuitable for medical use.
Neurons created from skin cells of elderly ALS patients
Less than 27 months after announcing that he had institutional permission to attempt the creation of patient and disease-specific stem cell lines, Harvard Stem Cell Institute (HSCI) Principal Faculty member Kevin Eggan today proclaimed the effort a success - though politically imposed restrictions and scientific advances prompted him to use a different technique than originally planned.
Fruit-fly study adds weight to theories about another type of adult stem cell
It turns out that an old dog - or at least an old fruit-fly cell - can learn new tricks. Researchers at the Stanford University School of Medicine have found that mature, specialized cells naturally regress to serve as a kind of de facto stem cell during the fruit-fly life cycle.
Scientists identify cells for spinal-cord repair
A researcher at MIT's Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer scarring cells following an injury, may lead to a new, non-surgical treatment for debilitating spinal-cord injuries.
The genetics of the white horse unraveled
The white horse is an icon for dignity which has had a huge impact on human culture across the world. An international team led by researchers at Uppsala University has now identified the mutation causing this spectacular trait and show that white horses carry an identical mutation that can be traced back to a common ancestor that lived thousands of years ago. The study is interesting for medical research since this mutation also enhance the risk for melanoma. The paper is published on July 20 on the website of
Nature Genetics.
Study identifies cells for spinal-cord repair
(PhysOrg.com) -- A researcher at MIT’s Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer scarring cells following an injury, may lead to a new, non-surgical treatment for debilitating spinal-cord injuries.
Cancer drug shows promise against graft vs. host disease
A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumors is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication for people who have had bone marrow transplants.